Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
Open Access
- 27 January 2022
- journal article
- editorial
- Published by Springer Nature in European Radiology
- Vol. 32 (3) , 1757-1759
Abstract
No abstract availableFunding Information
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
This publication has 12 references indexed in Scilit:
- Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLDClinical Gastroenterology and Hepatology, 2021
- Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysisLiver International, 2021
- On the value and limitations of liver histology in assessing non-alcoholic steatohepatitisJournal of Hepatology, 2020
- Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisGastroenterology, 2020
- Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal HypertensionRadiology, 2018
- Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virusAbdominal Radiology, 2018
- Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic FibrosisAmerican Journal of Roentgenology, 2016
- Chapter 4 Biomarkers Of Liver Fibrosis2008
- Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis StagesClinical Chemistry, 2007
- Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentationAlimentary Pharmacology & Therapeutics, 2007